A Scabies Mite Serpin Interferes with Complement-Mediated Neutrophil Functions and Promotes Staphylococcal Growth

PLoS Neglected Tropical Diseases

Volumn 8, Issue 6, 2014, Pages

  Swe, Pearl M ^a   Fischer, Katja ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR; SMSB 4; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; MIXED INFECTION; MOLECULAR CLONING; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; SARCOPTES SCABIEI; SCABIES; SECONDARY INFECTION; SERUM BACTERICIDAL ACTIVITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY;

ANIMALS; BLOOD BACTERICIDAL ACTIVITY; COMPLEMENT INACTIVATING AGENTS; HUMANS; IMMUNE TOLERANCE; MICROBIAL VIABILITY; NEUTROPHILS; SARCOPTES SCABIEI; SERPINS; STAPHYLOCOCCUS AUREUS;

EID: 84903476270     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002928     Document Type: Article

References (36)

1. Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, et al. (2013) Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis 7: e2167.
2. Fuller LC, (2013) Epidemiology of scabies. Curr Opin Infect Dis 26: 123-126.
3. Hay RJ, Steer AC, Engelman D, Walton S, (2012) Scabies in the developing world-its prevalence, complications, and management. Clin Microbiol Infect 18: 313-323.
4. Clucas DB, Carville KS, Connors C, Currie BJ, Carapetis JR, et al. (2008) Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ 86: 275-281.
5. Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ, (1997) Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 16: 494-499.
6. Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, et al. (2005) Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 83: 34-42.
7. Carapetis JR, Steer AC, Mulholland EK, Weber M, (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685-694.
8. Currie BJ, McCarthy JS, (2010) Permethrin and ivermectin for scabies. N Engl J Med 362: 717-725.
9. Tong SY, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, et al. (2009) Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis 199: 1461-1470.
10. Whitehall J, Kuzulugil D, Sheldrick K, Wood A, (2013) Burden of paediatric pyoderma and scabies in North West Queensland. J Paediatr Child Health 49: 141-143.
11. Ricklin D, Hajishengallis G, Yang K, Lambris JD, (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
12. Dahl MR, Thiel S, Matsushita M, Fujita T, Willis AC, et al. (2001) MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15: 127-135.
13. Sato T, Endo Y, Matsushita M, Fujita T, (1994) Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol 6: 665-669.
14. Thiel S, Vorup-Jensen T, Stover CM, Schwaeble W, Laursen SB, et al. (1997) A second serine protease associated with mannan-binding lectin that activates complement. Nature 386: 506-510.
15. Agarwal S, Ferreira VP, Cortes C, Pangburn MK, Rice PA, et al. (2010) An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol 185: 507-516.
16. Cortes C, Ferreira VP, Pangburn MK, (2011) Native properdin binds to Chlamydia pneumoniae and promotes complement activation. Infect Immun 79: 724-731.
17. Fearon DT, Austen KF, (1975) Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med 142: 856-863.
18. Ferreira VP, Cortes C, Pangburn MK, (2010) Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement. Immunobiology 215: 932-940.
19. Gros P, Milder FJ, Janssen BJ, (2008) Complement driven by conformational changes. Nat Rev Immunol 8: 48-58.
20. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, et al. (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6: 920-927.
21. Lee LY, Hook M, Haviland D, Wetsel RA, Yonter EO, et al. (2004) Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis 190: 571-579.
22. Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA, (2005) Anti-opsonic properties of staphylokinase. Microbes Infect 7: 476-484.
23. Laarman AJ, Ruyken M, Malone CL, van Strijp JA, Horswill AR, et al. (2011) Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 186: 6445-6453.
24. Bergstrom FC, Reynolds S, Johnstone M, Pike RN, Buckle AM, et al. (2009) Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol 182: 7809-7817.
25. Mika A, Reynolds SL, Mohlin FC, Willis C, Swe PM, et al. (2012) Novel scabies mite serpins inhibit the three pathways of the human complement system. PLoS One 7: e40489.
26. Mika A, Reynolds SL, Pickering D, McMillan D, Sriprakash KS, et al. (2012) Complement inhibitors from scabies mites promote streptococcal growth-a novel mechanism in infected epidermis? PLoS Negl Trop Dis 6: e1563.
27. Andrews RM, Kearns T, Connors C, Parker C, Carville K, et al. (2009) A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis 3: e554.
28. McDonald M, Dougall A, Holt D, Huygens F, Oppedisano F, et al. (2006) Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol 44: 3720-3727.
29. Holt DC, Holden MT, Tong SY, Castillo-Ramirez S, Clarke L, et al. (2011) A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol 3: 881-895.
30. Berends ET, Dekkers JF, Nijland R, Kuipers A, Soppe JA, et al. (2013) Distinct localization of the complement C5b-9 complex on Gram-positive bacteria. Cell Microbiol 15: 1955-1968.
31. Postma B, Poppelier MJ, van Galen JC, Prossnitz ER, van Strijp JA, et al. (2004) Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J Immunol 172: 6994-7001.
32. Rooijakkers SH, van Kessel KP, van Strijp JA, (2005) Staphylococcal innate immune evasion. Trends Microbiol 13: 596-601.
33. Willis C, Fischer K, Walton SF, Currie BJ, Kemp DJ, (2006) Scabies mite inactivated serine protease paralogues are present both internally in the mite gut and externally in feces. Am J Trop Med Hyg 75: 683-687.
34. Mika A, Goh P, Holt DC, Kemp DJ, Fischer K, (2011) Scabies mite peritrophins are potential targets of human host innate immunity. PLoS Negl Trop Dis 5: e1331.
35. Brouwer N, Dolman KM, van Zwieten R, Nieuwenhuys E, Hart M, et al. (2006) Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol 43: 2051-2060.
36. Shelley WB, Shelley ED, Burmeister V, (1988) Staphylococcus aureus colonization of burrows in erythrodermic Norwegian scabies. A case study of iatrogenic contagion. J Am Acad Dermatol 19: 673-678.